chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got / shot #1 / 16 months ago / appointment to receive / shot #2 / 01-Jul-2021 / pharmacist told / to start the series over; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose intramuscularly on upper arm 16 months ago.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The reporter was a patient.  The age at vaccination was not applicable for this report. The reporter did not have a computer (no email). She did not have the exact date of the 1st dose of Shingrix vaccine administered. She did not have the lot number available. She provided the contact information of the pharmacy where the 1st shot was given.  She had an appointment to receive Shingrix 2nd dose on 01st July 2021. She stated that pharmacist told her that since it has been 16 months, she had to start the series over. It was not confirmed, if the patient received 2nd dose till the time of reporting, which led to incomplete course of vaccination. The reporter consented to follow up.
Pt said the site of injection is red and warm to touch. She wanted us to report this because she never had some problem with prior immunizations.
Per patient report, he received Janssen COVID vaccine on 11/1/2021. Presented to our facility 11/23/2021 with bilateral facial nerve motor paralysis. Clinically atypical presentation but CSF studies compatible with Guillan-Barre syndrome. Patient received series of 5 plasma exchange procedures with mild improvement of symptoms, but not back to baseline.    Patient mentions pain during yawning the night prior to presentation, but no immediate paralysis. Difficult to imagine mechanical paralysis due to yawning as an etiology--but presentation is unusual. No clear-cut alternate etiology to presentation.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Levaquin, reaction(s): "she is allergic to Levaquin"; Z-pack, reaction(s): "she is allergic to z-pack". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "sore arm". Therapeutic measures were taken as a result of pain in extremity. Additional information: The patient asked if she needs to take the 2nd dose of covid-19 vaccine since she is allergic to Levaquin and z-pack. She experienced a sore arm after the first dose and took Tylenol, scheduled for the second dose on 24Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
given Hiberix reconstituted with sterile water; given Hiberix reconstituted with sterile water; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Hib (Hiberix) (batch number 594CF, expiry date 13th July 2022) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, it was possible that, the patient was given Hiberix that might have been incorrectly reconstituted with sterile water instead of saline, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. Healthcare professional did not have specific patient information or dates administered at the time of report.  The healthcare professional stated that, the specific lot was administered over a range of a couple of months.  The reporter consented to follow up. This was 1 of 9 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR024234:Same reporter US-GLAXOSMITHKLINE-US2022AMR024235:Same reporter US-GLAXOSMITHKLINE-US2022AMR024236:Same reporter US-GLAXOSMITHKLINE-US2022AMR024237:Same reporter US-GLAXOSMITHKLINE-US2022AMR024238:Same reporter US-GLAXOSMITHKLINE-US2022AMR024239:Same reporter US-GLAXOSMITHKLINE-US2022AMR024240:Same reporter US-GLAXOSMITHKLINE-US2022AMR024241:Same reporter
Pt given vaccine at 1020. Pt reported no S/S of dizziness or reaction 1023. Pt checking out at 1033 and was confused and emotional. Pt reported confusion, and could not answer simple questions. Laid pt down, gave water, and crackers. BP recheck and was 94/62. Physician evaluated pt and pt waited 30 additional minutes.
Information was received on 16-JAN-2018 from a lawyer regarding a case in litigation concerning a female patient, age not reported. The patient was vaccinated with ZOSTAVAX on or about 01-JAN-2015 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. Beginning on or about 01-MAR-2017, the patient began to break out with blistering vesicular lesions. The patient was treated at a healthcare facility and by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Outcome of herpes zoster and weakened immune symptoms was unknown. Additional information has been requested.
As soon as vaccine was given sharp pain across left chest which lasted at least one minute.Since then extremely sharp pain returns intermittently along with soreness in that whole general area.Shingles got worse.
Felt fine the rest of the night, but woke up and had body aches,  chills, fatigue, headache, congestion, nausea, shortness of breath and low grade fever.
Information has been received from a health professional concerning an 8 year old male with no known medical history or allergies who on November 14, 1998 was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (Lot #628149/1325H). There was no concomitant medication. The patient developed chickenpox near the end of November 2005. Unspecified medical attention was sought. Subsequently the patient fully recovered. There was no product quality complaint involved. Additional information has been request.
I received the flu shot on 10/13/2017, and by the end of the day on 10/14/17, I developed a rash on my hands and feet with severe itching. It did not respond to typical over the counter hydrocortisone and diphenhydramine creams/ointments. I went to the dermatologist a week later because it had not resolved. He began a course of high dose oral prednisone and also diagnosed it as erythema multiforme. I am a healthcare provider myself. The rash resolved approximately 14 days after the initial injection. I have never had a reaction to any type of influenza vaccine and not allergic to eggs.
Information has been received from a licensed practical nurse concerning a 15 year old female patient with no pertinent medical history and no drug reactions/allergies who on 27-JUL-2009 was vaccinated with the first 0.5mL dose of GARDASIL (lot# 661953/1130X) IM. Secondary suspect vaccination on the same day included a dose of varicella virus vaccine live (duration and dose not reported). Other concomitant therapies included hormonal contraceptives (unspecified) and RETIN-A topical cream. On 27-JUL-2009 the patient fainted after receiving her first dose of vaccination. On the same day, the patient recovered from fainting. On 08-OCT-2009 the patient was vaccinated with the second 0.5mL dose of GARDASIL (lot# 663453/0249Y) IM. The patient's "throat felts tight" while she was still in the office after receiving her second dose of vaccination. No laboratory diagnostic studies were performed. The patient was treated with BENADRYL while she was in the physician's office after dose number two. On the same day the patient recovered from throat tightness. Additional information has been requested.
Pt came into the clinic very nervous about getting immunizations to travel. After immunizations were given patient stated that she felt fine when questioned. Patient was taken to front desk for check out. While checking out the patient reported feeling dizzy. Patient was directed back to Immunization clinic. Nurse assessed patient and had her prop her legs in the chair. Cool compress was placed on back of patients neck and well as under her chin. Patient was able to talk to nurse through out ordeal. Patient did report that she could hear but it was difficult to hear what nurse was saying at first. BP checked at 1:45 pm 79/53. Patient c/o nausea but never vomit. Patient was given a  Coke w/ peanut butter crackers and she was able to tolerate that. BP checked @ 1:50pm 79/56 P-54. Patient continue to talk to nurses about up coming trip. BP checked @ 1:57 pm 93/70 P-57. Patient stated that she felt better and felt more like herself. BP checked @2:05 pm 97/73 P-63. Nurse had patient take feet out of chair and for patient to remain seated for a few mins. Patient stated again that she was feeling better. Denies dizziness. Patient was advised to wait in lobby an additional 15 mins before she was able to leave facility.
First day - Cold sweats, Fever, Chills, Headache, Nausea, Diarrhea, Body aches, Extreme back pain. Second day - Back pain, Nausea, No fever
I began experiencing abnormally heavy bleeding and uterine cramping/pressure after my first cycle after my final vaccination. Pain relief medication did not give relief. Pain and pressure were so severe that I went to the ER to make sure I was okay. After this, I had 3 cycles in one month; I typically have a cycle every 25-28 days.
Mild general pain / pain in the body; Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Mild general pain / pain in the body) and PAIN IN EXTREMITY (Pain in the arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Mild general pain / pain in the body) and PAIN IN EXTREMITY (Pain in the arm). At the time of the report, PAIN (Mild general pain / pain in the body) and PAIN IN EXTREMITY (Pain in the arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications reported.  No treatment information was reported by reporter.   This case was linked to MOD-2021-313125 (Patient Link).   Reporter did not allow further contact
p/vax pt & mom went to McDonalds & pt c/o dizziness;mom sat pt in booth & instructed to take deep breaths & relax;when mom was ordering, pt came to mom & said felt sick @ stomach;pt passed out, fell & hit floor;pale, sz;to hosp w/mom
Covid arm; rash/break out of a rash on her forearm that almost looked liked hives/rash the size of baseball; reported being tired; arm was achy; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Covid arm), PAIN IN EXTREMITY (arm was achy), RASH (rash/break out of a rash on her forearm that almost looked liked hives/rash the size of baseball) and FATIGUE (reported being tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was achy) and FATIGUE (reported being tired). On 13-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid arm) and RASH (rash/break out of a rash on her forearm that almost looked liked hives/rash the size of baseball). At the time of the report, VACCINATION SITE REACTION (Covid arm), PAIN IN EXTREMITY (arm was achy), RASH (rash/break out of a rash on her forearm that almost looked liked hives/rash the size of baseball) and FATIGUE (reported being tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Pt. received first pediatric dose of Pfizer Covid vaccine.  Pt c/o nausea with in 10 minutes of arriving in post vac. Pt was pale...pt assisted to stretcher and laid flat.  Initial vital signs at 10:44 am 98% O2 108/58 HR 80 and 18 Resp.  Given cool wash cloth to back of neck and forehead.   10:55 vitals 108/74  O2 99% HR 94 and 18 resp.    Pt states feeling better.  Color good, had pt sit up given a popcicle and goldfish snack.
Swelling, redness, very warm to the touch. Hurts to lift entire arm. Shot was given in left upper arm. Hurts very bad and limits activities I can perform.
12/21/2020 HAD VACCINATION 12/22/2020 WOKE AT 3AM, FELT HA, EYES FELT LIKE HAD FEVER, DIDNT FEEL GOOD. TRIED 3XS TO GET UP. TEMP 99.9. WENT BACK TO SLEEP. DID NOT GO TO WORK. R ARM WAS SO SORE, COULD NOT MOVE OR PICK UP ANYTHING. POLICY AT WORK TO CALL COVID HOTLINE; COVID TEST 12/23/2020  FEVER, FATIGUE, BODY ACHES 12/24/2020 COVID TEST; NEGATIVE. NO FEVER. FATIGUE, SLEEPING ALL DAY.  HAD TO BE CLEARED BY OCCUPATIONAL HEALTH TO WORK. CAME BACK TO WORK ON TUESDAY.  12/30/2020  FELT BETTER
Nov 7 was the vaccine, Nov 8 i had covid symptoms including fever, Nov 11 i ended up in the ER with head numbness/pressure, numbness in hands. Nov 30 i started having fatigue that is still ongoing. Dec 8 i ended up in the ER with fatigue, shaking, dizziness, palpitations.
Fully vaccinated patient admitted to hospital with diagnosis of COVID per PCR.  Patient admitted to the hospital on 06/21/21 for left sided upped abdominal pain.  Diagnosed with pancreatitis.  During admission testing patient has a detected PCR test for COVID.  Patient remained asymptomatic for COVID throughout his stay.  Discharged on 06/23/2021.
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Moderna COVID-19 vaccine administered to patient post temperature excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patient post temperature excursion).    This case contains information for the 21st of 104 patients described by the reporter.  Concomitant product use was not provided by the reporter.  It was reported there was a temperature excursion between 26-May-2022 to 30-Sep-2022 and lot AR5186C was affected between 08-Sep-2022 to 27-Sep-2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 01-Aug-2022 and individual vials were put in the refrigerator on the day of use.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:Master case
Pt had swelling of lt &rt eyes /w red rash that itched &burned on 14Mar91.F/U @ PMD did not improve but worsened &was seen in ER on 17Mar91-Max T 99.TX /w Hydrocortisone,Benadryl,Prednisone-2Apr91 Pt has some swelling from allergic rxn.
After second vaccine I noticed increased heart rate. By the 5th day after my second dose I had a resting heart rate above 130 and on a jog over 200bpm Since I?ve been diagnosed with Graves? disease and am still seeking treatment
Covid arm/ pain/ intense itchiness/ stiffnes; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE REACTION (Covid arm/ pain/ intense itchiness/ stiffnes) in a 6-decade-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no known allergies to vaccines, medications, food and other products.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION SITE REACTION (Covid arm/ pain/ intense itchiness/ stiffnes). At the time of the report, VACCINATION SITE REACTION (Covid arm/ pain/ intense itchiness/ stiffnes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported as mid 50s.   No concomitant medication was provided.  It was reported that in 2021, patient had experienced covid arm after received the moderna vaccine dose and symptoms reported included pain and intense itchiness, stiffness that lasted for more than 2 weeks before subsided.   It was unknown that the event caused the patient to seek medical care.   Treatment medication was not provided by the reporter.
S/S redness and swelling, hot to touch increase temp. TX Motrin as directed. Apply cold packs to affected area right deltoid.
All over body itchiness, varying in location with no physical rash or marks started 1 week after first dose. On feb 1st, after about 5 days of itchiness I developed rash at injection site, redness, hives, itchiness. Took Benadryl and itchiness and rash went away temporarily.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 02-OCT-2014 the patient was vaccinated with (Oka/Merck) VARIVAX (0.5 ml, subcutaneous, lot # J012371, expiry date: 03-OCT-2015) which underwent a temperature excursion prior to being administered. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Itching; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 38-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6207, Expiration date: Jul2021), via an unspecified route of administration in the left arm on 30Mar2021 at 08:15 or 08:30 (at the age of 38-year-old) as single dose for COVID-19 immunisation. Medical history included high blood pressure and hypertension from Aug2015 and ongoing; COVID on an unknown date in Dec2020 and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications were not reported. No investigation assessment was provided. The patient stated she had the 1st dose of the Pfizer vaccine yesterday', 30Mar2021 and itching began at 17:00 that same day yesterday evening' and she was just itching, and it was a lot of itching all over and could not find anything in her system and did not see anything anywhere and she was not allergic to anything. She was asking if this was a possible side effect of the vaccine. She said that the itching got worse and started at 17:00 yesterday and now was about the same as when it began. The patient stated she has not yet had treatment, has not gone to the emergency room or to the HCP (health care professional) and was hoping the itching would go away; stated she was taking Benadryl unsure of the dosage and was hoping the itching would go away with Benadryl. She did take the Benadryl before she went to bed last night and took one tablet but does not know the dosage. She got the Pfizer vaccine because she just wanted to hurry up and get it because she had COVID on an unknown date in Dec2020. She was fine yesterday and prior to this right now she was doing testing on her thyroid but has no results to provide; stated she has not seen a specialist yet and was still waiting to see the specialist; stated her last blood work was on Thursday, 25Mar2021 and they were checking her levels, but she has no results. The event was not resulted in emergency room nor physician's office visit. The patient underwent lab tests and procedures which included thyroid function test: no results on 25Mar2021 - checking her levels but she has no results. The outcome of the event was unknown.  Follow-up attempts are needed. Further information is expected.
I?m sick weak headaches chills ... dizzy loud ringing in ears . I?ve never been so sick in my life
pt recv vax & 5hr p/vax pt exp fatigue & sleepiness;sx resolved;
Redness, itching , pain around injection site. Sxs began around 7 hours after vaccine was administered. Tylenol and 1% hydrocortisone cream (along with ice 15 min 2 times a day ) to injection site.
I got my period 19 days early, 6 days after I received my 2nd Pfizer vaccination.  I am on oral birth control - Gemmily.
Nausea, anorexia; extreme fatigue; dizziness; pain under ears; chills; low blood pressure; blood sugar drops despite adequate glucose - duration: lasting over one week.